Literature DB >> 1662603

Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type.

O Slodowski1, J Böhm, B Schöne, B Otto.   

Abstract

The biological function of the 20 C-terminal amino acids of human interferon-gamma (IFN-gamma) was examined by recombinant DNA methodology. Six truncated IFN-gamma analogues were produced by modification of the 3' end of the coding sequence of the cloned gene, insertion into a vector with the trc promoter and expression of the recombinant IFN-gamma analogue genes in Escherichia coli strain JM 105. The IFN-gamma analogue proteins were shortened by 10 (C-10L), 11 (C-11, C-11L), 14 (C-14L), 19 (C-19L) and 20 (C-20) amino acid. Four of these constructs were modified to have a C-terminal leucine. The expression rates of precipitating IFN-gamma variants in E. coli cells (wild type, C-10L, C-11, C-11L) amount to 35-40% of the total protein, in contrast to 14-21% for the mainly soluble ones (C-14L, C-20). The variant C-19L has an exceptional position in its solubility behaviour with a nearly 1:1 distribution between its soluble and insoluble form by an expression rate of 8%. The purification protocol of the insoluble variants contains a denaturing and a renaturation step. The characteristic step for purification soluble IFN-gamma is HPLC cation-exchange chromatography. The antiviral activities of the variants lacking 14 or more amino acids are less than 2% of the wild-type activity. The variants C-10L, C-11 and C-11L show higher biological activities than wild-type IFN-gamma. The most active variant, C-10L, with leucine as the last C-terminal amino acid, has a fourfold higher specific antiviral activity (A549 cells, encephalomyocarditis virus). Removal, but not replacement of the leucine, represented by the variant C-11, reduces the biological activity compared with variant C-10L. The activity of C-11 is, nevertheless, higher than in the wild type. Comparing the secondary structures, as judged by CD analyses, no significant differences for C-10L, C-14L and C-20, compared with wild type, are observed. Also, all molecules, including the wild-type protein, exist as dimers under physiological conditions. There is a correlation between the grade of truncation and the pI values, which range from pI = 10.4 (wild type) to pI = 8.0 (C-20). The variant C-10L demonstrates a higher temperature stability (tm = 55 degrees C) compared with wild type (tm = 53 degrees C). Perhaps this higher stability will result in a longer half-life in vivo.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662603     DOI: 10.1111/j.1432-1033.1991.tb16481.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Pressure- and temperature-induced unfolding and aggregation of recombinant human interferon-gamma: a Fourier transform infrared spectroscopy study.

Authors:  Koen Goossens; Joost Haelewyn; Filip Meersman; Marc De Ley; Karel Heremans
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.

Authors:  J Haelewyn; L Michiels; P Verhaert; M F Hoylaerts; R Witters; M De Ley
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

3.  Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris.

Authors:  You-Feng Yang; Han-Ying Yuan; Nan-Song Liu; Xiang-Ling Chen; Bu-Yu Gao; Hong Lu; Yu-Yang Li
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

4.  Nuclear accumulation of interferon gamma.

Authors:  T Bader; J Weitzerbin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  Recombinant IFN-γ from the bank vole Myodes glareolus: a novel tool for research on rodent reservoirs of zoonotic pathogens.

Authors:  Francesca Torelli; Steffen Zander; Heinz Ellerbrok; Georg Kochs; Rainer G Ulrich; Christian Klotz; Frank Seeber
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

6.  Cloning, expression and antiviral activity of IFNγ from the Australian fruit bat, Pteropus alecto.

Authors:  Vijaya Janardhana; Mary Tachedjian; Gary Crameri; Chris Cowled; Lin-Fa Wang; Michelle L Baker
Journal:  Dev Comp Immunol       Date:  2011-11-07       Impact factor: 3.636

7.  Heparan Sulfate Facilitates Binding of hIFNγ to Its Cell-Surface Receptor hIFNGR1.

Authors:  Elisaveta Miladinova; Elena Lilkova; Elena Krachmarova; Kristina Malinova; Peicho Petkov; Nevena Ilieva; Genoveva Nacheva; Leandar Litov
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.